Please check your internet connection and try again.
# Diadzein, Genistein, and Palmitoylethanolamide
## Overview
This combination contains isoflavones (diadzein and genistein) derived from soy and palmitoylethanolamide (PEA), an endogenous fatty acid amide. Isoflavones are proposed to have weak estrogenic activity, while PEA is involved in pain and inflammation modulation.
## Primary Indications
There are no FDA-approved indications for this specific combination. It is often marketed as a dietary supplement for various conditions, including menopausal symptoms, joint pain, and inflammation. Evidence supporting efficacy for these uses is limited and often extrapolated from studies of individual components.
## Adult Dosing
* **Diadzein and Genistein:** Doses can vary widely in supplements. Typical ranges found in research studies for menopausal symptoms or bone health range from 20-80 mg of each isoflavone daily.
* **Palmitoylethanolamide (PEA):** Doses can range from 300 mg to 1200 mg daily, often divided into two doses, for pain and inflammation.
**Note:** Specific dosing for this combination is not established and depends on the product formulation and the intended use.
## Pediatric Dosing
There is no established pediatric dosing for this combination.
## Dose Adjustments
No specific dose adjustments are established for renal or hepatic impairment due to the lack of approved indications and standardized dosing.
## Contraindications
* Hypersensitivity to any component of the formulation.
* Pregnancy and breastfeeding (due to potential hormonal effects of isoflavones).
* Individuals with hormone-sensitive cancers (e.g., breast, ovarian, uterine) should exercise extreme caution or avoid, due to potential estrogenic activity of isoflavones, although evidence is conflicting.
## Adverse Effects
* **Gastrointestinal:** Nausea, abdominal discomfort, diarrhea, constipation.
* **Hormonal/Endocrine:** Potential for menstrual irregularities, breast tenderness (primarily associated with isoflavones).
* **Allergic Reactions:** Rash, itching.
* **Other:** Headache, dizziness.
## Key Drug Interactions
* **Hormone Therapies:** Potential for additive effects or interference with hormone replacement therapy or oral contraceptives.
* **Tamoxifen:** Isoflavones may interact with tamoxifen due to their potential estrogenic activity.
* **Thyroid Medications:** Soy isoflavones have been suggested to interfere with thyroid hormone absorption. Separate administration by at least 4 hours.
## Monitoring
* Monitor for any signs of allergic reaction or significant adverse effects.
* For individuals with hormone-sensitive conditions, monitor for changes suggestive of hormonal influence.
## Clinical Pearls
* This combination is typically available as a dietary supplement, not a prescription medication.
* Efficacy and safety data are limited, especially for the combination product.
* Patients should be advised that "natural" does not always mean "safe" and potential interactions and side effects exist.
* Consultation with a healthcare provider is recommended before initiating this supplement, particularly for patients with pre-existing conditions or those taking other medications.
***
*Disclaimer: This information is intended for clinical use and is not a substitute for professional medical advice. Always verify current prescribing information and consult with a qualified healthcare provider before making any decisions related to patient care.*
